PP Influence of sacubitril/ valsartan on biochemical markers in patients with chronic heart failure after COVID-19

被引：0
|
作者：
Minovarova, C. [1 ]
Atadjanova, G. [1 ]
Uzokov, J. [2 ]
Tursunov, J. [3 ]
机构：
[1] Tashkent Paediat Med Inst, Tashkent, Uzbekistan
[2] Republican Specialized Sci Pract Med Ctr Therapy, Tashkent, Uzbekistan
[3] JackSoft Clin, Tashkent, Uzbekistan
来源：
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION | 2024年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
58ASM - 14
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Reverse myocardial remodeling and reduction of inflammatory markers in patients with heart failure treated with sacubitril/valsartan
    Porcile, Rafael
    Zuniga Infantas, Maria T.
    Levin, Ricardo
    Perez Baztarrica, Gabriel
    Salvaggio, Flavio
    Botbol, Livio A.
    INSUFICIENCIA CARDIACA, 2018, 13 (03) : 104 - 109
  • [32] Influence of diabetes on sacubitril/valsartan titration and clinical outcomes in patients hospitalized for heart failure
    Witte, Klaus K.
    Wachter, Rolf
    Senni, Michele
    Belohlavek, Jan
    Straburzynska-Migaj, Ewa
    Fonseca, Candida
    Lonn, Eva
    Noe, Adele
    Schwende, Heike
    Butylin, Dmytro
    Chiang, YannTong
    Pascual-Figal, Domingo
    ESC HEART FAILURE, 2023, 10 (01): : 80 - 89
  • [33] Impact of the COVID-19 pandemic on prescription of sacubitril/valsartan in Italy
    Rosano, Giuseppe M. C.
    Celant, Simone
    Olimpieri, Pier Paolo
    Colatrella, Antonietta
    Onder, Graziano
    Di Lenarda, Andrea
    Ambrosio, Giuseppe
    Reboldi, Gianpaolo
    Gensini, Gian Franco
    Colivicchi, Furio
    Russo, Pierluigi
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (05) : 855 - 860
  • [34] Reduction in rate of hospitalizations of patients with heart failure after treatment with sacubitril/valsartan.
    Caples, N.
    Cronin, E.
    Owens, P.
    Oconnor, C.
    Ocallaghan, P.
    Kumar, J.
    Asegdom, S.
    EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING, 2018, 17 : 29 - 29
  • [35] Renal protective effect of sacubitril/valsartan in patients with heart failure
    Hui-Ling Hsieh
    Chun-You Chen
    Cheng-Hsien Chen
    Shih-Chang Hsu
    Wen-Cheng Huang
    Yuh-Mou Sue
    Feng-Yen Lin
    Chun-Ming Shih
    Yue-Cune Chang
    Po-Hsun Huang
    Chung-Te Liu
    Scientific Reports, 11
  • [36] The Effect of Sacubitril/Valsartan on Selvester Score in Heart Failure Patients
    Ulusan, Sebahat
    Peynirci, Ahmet
    Ozdil, Omer
    Sahin, Adnan
    Kuyumcu, Mevlut Serdar
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2023, 142 : S9 - S10
  • [37] Renal protective effect of sacubitril/valsartan in patients with heart failure
    Hsieh, Hui-Ling
    Chen, Chun-You
    Chen, Cheng-Hsien
    Hsu, Shih-Chang
    Huang, Wen-Cheng
    Sue, Yuh-Mou
    Lin, Feng-Yen
    Shih, Chun-Ming
    Chang, Yue-Cune
    Huang, Po-Hsun
    Chung-Te Liu
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [38] Perceived Barriers to Sacubitril/Valsartan Use in Patients with Heart Failure
    Shah, Kevin S.
    Ziaeian, Boback
    Mody, Freny V.
    Nsair, Ali
    Fonarow, Gregg C.
    JOURNAL OF CARDIAC FAILURE, 2018, 24 (08) : S99 - S99
  • [39] Effectiveness of sacubitril-valsartan in cancer patients with heart failure
    Martin-Garcia, Ana
    Lopez-Fernandez, Teresa
    Mitroi, Cristina
    Chaparro-Munoz, Marinela
    Moliner, Pedro
    Martin-Garcia, Agustin C.
    Martinez-Monzonis, Amparo
    Castro, Antonio
    Lopez-Sendon, Jose L.
    Sanchez, Pedro L.
    ESC HEART FAILURE, 2020, 7 (02): : 763 - 767
  • [40] Hyperkalemia, Sacubitril/Valsartan, and Mineralocorticoid Antagonists in Patients With Heart Failure
    Ezekowitz, Justin A.
    JAMA CARDIOLOGY, 2017, 2 (01) : 86 - 87
12345